Re: AGM Content

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Reply New Message

Prev Message Back To Forum Threaded View Next Message

Toinv

Rank: President [?]

Points: 4445 [?]

Votes: 35 Score: 3.7 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: AGM Content

posted on Oct 14, 2021 11:20AM

I fear you are correct jonzo.

I've let the hope that after 11 years invested in Zen/RVX I would finally make a buck or 2. I've let my mind get clouded by the false expectations set up by Don when he said...you'll be amazed how fast cancer trials move.

There probably won't be any money here until the investment bankers take over.

I guess it is nice to watch the science develop.

GLTA

Toinv

2 Recommendations

Reply New Message

Prev Message Back To Forum Threaded View Next Message

Please to post a reply